1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Grape King Bio Ltd

Grape King Bio Ltd

1707.TW
Grape King Bio LtdTW flagTaiwan Stock Exchange
91.10
TWD
-2.10
- -
13.50BMarket Cap

Total Valuation

Grape King Bio Ltd carries a market capitalization of 13.50B, placing it among publicly traded companies globally. Its enterprise value stands at 16.40B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap13.50B
Enterprise Value16.40B

Share Statistics

Grape King Bio Ltd currently has 148.14M shares outstanding.

Shares Outstanding148.14M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Grape King Bio Ltd trades at a trailing price-to-earnings ratio of 15.38. The price-to-sales ratio is 1.83, and the price-to-book ratio stands at 3.39.

PE Ratio15.38
PS Ratio1.83
PB Ratio3.39
P/TBV Ratio1.57
P/FCF Ratio7.11
P/OCF Ratio8.60

Enterprise Valuation

On an enterprise value basis, Grape King Bio Ltd trades at an EV/EBITDA multiple of 7.66 and an EV/FCF ratio of 6.20. The EV/Sales ratio of 1.60 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.66 provides insight into valuation relative to core operating earnings.

EV / Sales1.60
EV / EBITDA7.66
EV / EBIT7.66
EV / FCF6.20

Financial Position

Grape King Bio Ltd maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.78, indicating elevated leverage, while an interest coverage ratio of 451.02 demonstrates strong ability to service its debt obligations.

Current Ratio1.65
Quick Ratio1.25
Debt / Equity1.78
Debt / EBITDA0.10
Interest Coverage451.02

Financial Efficiency

Grape King Bio Ltd posts a return on equity of 22.12 and a return on invested capital of 13.72.

Return on Equity (ROE)22.12
Return on Assets (ROA)7.84
Return on Invested Capital (ROIC)13.72
Return on Capital Employed (ROCE)7.80
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.23

Taxes

Over the trailing twelve months, Grape King Bio Ltd has paid 436.77M in income taxes, reflecting an effective tax rate of 19.01.

Income Tax436.77M
Effective Tax Rate19.01

Stock Price Statistics

Grape King Bio Ltd's stock has declined approximately -26.53226% over the past 52 weeks. The 50-day moving average sits at 103.37, while the 200-day moving average is 118.91.

Beta (5Y)N/A
52-Week Price Change-26.53226%
50-Day Moving Average103.37
200-Day Moving Average118.91
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Grape King Bio Ltd generated 10.25B in revenue and converted that into 1.22B in net income, yielding earnings per share of 12.52. EBITDA reached 2.14B, while operating income came in at 2.14B.

Revenue10.25B
Gross Profit7.70B
Operating Income2.14B
Pretax Income2.30B
Net Income1.22B
EBITDA2.14B
EBIT2.14B
Earnings Per Share (EPS)12.52

Balance Sheet

Grape King Bio Ltd holds 4.28B in cash and equivalents against 215.03M in total debt, resulting in a net debt position of -4.16B. Total book value stands at 5.53B, with working capital of 2.24B providing operational flexibility.

Cash & Cash Equivalents4.28B
Total Debt215.03M
Net Debt-4.16B
Equity (Book Value)5.53B
Book Value Per Share37.33
Working Capital2.24B

Cash Flow

Grape King Bio Ltd produced 2.18B in operating cash flow over the past twelve months. After subtracting -463.64M in capital expenditures, free cash flow totaled 1.72B - equivalent to 11.59 per share.

Operating Cash Flow2.18B
Capital Expenditures-463.64M
Free Cash Flow1.72B
FCF Per Share11.59

Margins

Grape King Bio Ltd operates with a gross margin of 75.08, reflecting its pricing power and cost economics. The operating margin of 20.88 and net profit margin of 11.88 provide insight into operational efficiency.

Gross Margin75.08
Operating Margin20.88
Pretax Margin22.41
Profit Margin11.88
EBITDA Margin20.88

Dividends & Yields

The company's payout ratio of 40.83 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share6.90
Dividend YieldN/A
Payout Ratio40.83
Shareholder Yield9.31
FCF Yield14.06

Stock Splits

Grape King Bio Ltd's most recent stock split took place on September 15, 2005 with a 50:51 split ratio.

Last Split Date9/15/2005
Split Ratio50:51

Scores

Grape King Bio Ltd posts an Altman Z-Score of 4.70, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.70